Work

Utilization of L-type amino acid transporter 1 (LAT1) for targeted prodrug delivery

Year: 2023
Type: dissertation
Abstract: Many central nervous system (CNS) related diseases and cancer therapies suffer from challenges often related to the problems in targeting drugs to desired cells and tissues.The blood-brain barrier (BBB) and brain parenchymal cells effectively hinder drugs from entering the brain.In cancer cells, efflux transporters are responsible for pumping drugs out of the cells, among other chemoresistance mechanisms.L-type amino acid transporter 1 (LAT1), a member of the solute carrier transporter (SLC) family, is able to transport drugs in addition to its natural substrates.LAT1 is known to be highly expressed in the BBB and moreover, it is overexpressed in several cancer types.In this thesis, we studied the possible utilization of LAT1 for brain-and cancer-targeted prodrug delivery.This study is the first to show that LAT1 is expressed and functional in the cell membrane of mouse primary neurons, astrocytes, and immortalized microglia and its function also seems to be unaltered in Alzheimer's disease pathology.Therefore, drug transport via LAT1 is an interesting possibility for enhancing targeted delivery in the brain parenchyma.This study also revealed that LAT1 could also be useful in targeting inhibitors of efflux transporters in cancer cells.Our prodrugs of efflux inhibitor probenecid increased cellular accumulation and the anti-8 proliferative effect of co-administered vinblastine.However, with another studied anticancer agent methotrexate, this phenomenon could not be achieved.This emphasizes the importance of careful prodrug design and evaluation of the suitable prodrug-chemotherapeutic combination.We also noticed that LAT1-prodrugs can utilize secondary transport mechanisms, namely organic anion transporting polypeptides (OATPs).This occurred especially with high concentrations of prodrugs.Since these secondary mechanisms may affect the drug delivery when the primary transporter is unavailable, it is essential to understand their role when designing prodrugs.Even though completely specific LAT1-targeting is impossible to achieve, the secondary transport mechanisms may also be a possibility for improving the prodrugs brain accumulation e.g., via OATP1A2 which is highly expressed in the BBB.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7215367731
Cites: 171
Cited by:
Related to: 10